<DOC>
	<DOCNO>NCT00338260</DOCNO>
	<brief_summary>The LIFE study conduct 1995-2001 . This study conduct 9193 patient high blood pressure thicken main pump chamber heart . The result show average treatment time 4.8 year , treatment base losartan well treatment base atenolol reduce risk stroke . The main study result publish Dahlof et al . Lancet 2002 ; 359:995-1003 .</brief_summary>
	<brief_title>Losartan Intervention For Endpoint Reduction Hypertension ( LIFE ) Study ( 0954-133 )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy , Left Ventricular</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age 55 80 year Males females Hypertension ( 160200/95115 mm Hg ECG evidence leave ventricular hypertrophy Need treatment angiotensin convert enzyme inhibitor , open label angiotensin receptor blocker betablockers Myocardial infarction stroke within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>